US-Listed Biological Products, (No Diagnostic Substances) — Total Assets Percentiles, FY 2019

Population: 156 US-listed companies (SIC 2836), fiscal year 2019; fiscal year ends 2019-06-30 to 2020-05-31.

Fiscal year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · latest

10th percentile	$4.5M
25th percentile	$29.6M
Median	$127.1M
75th percentile	$329.4M
90th percentile	$717.6M
Mean	$1.2B
Minimum	$93
Maximum	$61.6B

Methodology & sources
Total Assets as filed, one fiscal year per company; percentiles computed in the database via percentile_cont, never by a model. Fiscal year 2019 = fiscal years ending 2019-06-01 to 2020-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-02.

Evidence samples

Latest Total Assets percentiles (live) · All Biological Products, (No Diagnostic Substances) benchmarks · All industries

Cite as: FACTANKER, https://factanker.com/industries/sic-2836/total-assets/2019